EHMT inhibition can also reduce the level of hyperphosphorylated tau, thus improving AD symptoms (Wang et al. 2021a), but the relationship between EMHT2 and AD immunity has not been studied in detail. This evidence concerns the gene MAPT and Alzheimer disease.